Key result
Claudin-14 rs219755 minor allele linked to ~45% lower 24-hour calcium excretion versus major allele.
Why the study?
Are claudin-14, claudin-16, and claudin-19 single-nucleotide polymorphisms associated with urine calcium excretion in patients with hypertension?
Observational (n=393)
No
Are claudin-14, claudin-16, and claudin-19 single-nucleotide polymorphisms associated with urine calcium excretion in patients with hypertension?
Claudin-14 gene polymorphisms at the 3' region are significantly associated with 24-hour and post-saline infusion urine calcium excretion in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Claudin-14 rs219755 SNP was associated with calcium excretion in hypertension; hypothesis-generating for genetic hypercalciuria risk, needs prospective validation.
Background and objectives Claudin-16 and -19 are proteins forming pores for the paracellular reabsorption of divalent cations in the ascending limb of Henle loop; conversely, claudin-14 decreases ion permeability of these pores. Single-nucleotide polymorphisms in gene coding for claudin-14 were associated with kidney stones and calcium excretion. This study aimed to explore the association of claudin-14 , claudin-16 , and claudin-19 single-nucleotide polymorphisms with calcium excretion. Design, setting, participants, & measurements We performed a retrospective observational study of 393 patients with hypertension who were naïve to antihypertensive drugs, in whom we measured 24-hour urine calcium excretion; history of kidney stones was ascertained by interview; 370 of these patients underwent an intravenous 0.9% sodium chloride infusion (2 L in 2 hours) to evaluate the response of calcium excretion in three different 2-hour urine samples collected before, during, and after saline infusion. Genotypes of claudin-14 , claudin-16 , and claudin-19 were obtained from data of a previous genome-wide association study in the same patients. Results Thirty-one single-nucleotide polymorphisms of the 3′ region of the claudin-14 gene were significantly associated with 24-hour calcium excretion and calcium excretion after saline infusion. The most significant associated single-nucleotide polymorphism was rs219755 (24-hour calcium excretion in GG, 225±124 mg/24 hours; 24-hour calcium excretion in GA, 194±100 mg/24 hours; 24-hour calcium excretion in AA, 124±73 mg/24 hours; P <0.001; calcium excretion during saline infusion in GG, 30±21 mg/2 hours; calcium excretion during saline infusion in GA, 29±18 mg/2 hours; calcium excretion during saline infusion in AA, 17±11 mg/2 hours; P =0.03). No significant associations were found among claudin-16 and claudin-19 single-nucleotide polymorphisms and calcium excretion and between claudin-14 , claudin-16 , and claudin-19 single-nucleotide polymorphisms and stones. Bioinformatic analysis showed that one single-nucleotide polymorphism at claudin-14 among those associated with calcium excretion may potentially influence splicing of transcript. Conclusions Claudin-14 genotype at the 3′ region is associated with calcium excretion in 24-hour urine and after the calciuretic stimulus of saline infusion.
No takes yet. Share an insight, caveat, or question.
Arcidiacono et al. (2018) conducted an observational in Essential hypertension (n=393). Claudin-14 gene polymorphism rs219755 (AA genotype) vs. Claudin-14 gene polymorphism rs219755 (GG genotype) was evaluated on 24-hour calcium excretion (p=<0.001). The claudin-14 single-nucleotide polymorphism rs219755 minor allele (AA) was significantly associated with lower 24-hour calcium excretion compared to the major allele (GG) (124 vs 225 mg/24 hours, P<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: